Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
Small AAA: Routine repair not advised
You may also be interested in...
FDA Panel Strongly Endorses Oceana's Solesta Fecal Incontinence Product
An FDA advisory panel offered strong support Dec. 2 to Ocean Therapeutics' effort to win PMA approval for its Solesta injectable bulking agent for fecal incontinence.
First Bioengineered Bladders In Humans Show Positive Results
The concept of bioengineered organs as a practical clinical strategy began, last week, to take shape - the oval-like shape of a bladder
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.